Brain cancer prediction is evolving with the introduction of advanced artificial intelligence (AI) tools that significantly enhance our understanding of recurrence risk in pediatric patients.Recent research from Mass General Brigham demonstrates that machine learning in oncology can outperform traditional prediction methods by analyzing multiple MRI scans over time.